beHuman Corp.

beHuman Corp. is a US-based company specializing in preventive cancer screening, offering a suite of services designed to detect various cancers at earlier stages to enhance successful treatment outcomes. beHuman Corp. is focused on preventive cancer screenings and was founded in 2025 in Sunny Isles Beach, US.

The company has completed 1 deal, with its latest funding round being Seed, raising USD 4 million led by Sante Ventures with participation from DHVP on February 4, 2026. The current company valuation stands at USD 10. 886 million. The CEO, Steve Yaskin is the founder of beHuman Corp.

beHuman specializes in preventive cancer screening, offering a comprehensive suite of services designed to detect various cancers at earlier stages. Their core offerings include genetic testing for hereditary cancer risk, guideline-based screenings for breast, cervical, colorectal, lung, and prostate cancers, and advanced diagnostics like low-dose CT scans. The process begins with a virtual consultation to assess personal medical histories, after which appropriate tests are coordinated, serving individuals who have historically been underserved in preventive care primarily across the United States. beHuman generates revenue through insurance-covered preventive cancer screenings and follow-up services.

Their model is based on direct transactions with consumers, facilitated by a virtual care team coordinating testing through existing healthcare providers and labs. They verify insurance coverage before ordering tests to avoid unexpected costs for patients. Their services are typically billed to insurance providers, establishing a business-to-business relationship alongside direct consumer engagement, thereby facilitating access to preventive services covered by most insurance plans. In February 2026, beHuman Corp.

raised USD 4. 000 mn in Seed funding led by Sante Ventures, with participation from DHVP. The funding will support the company's growth and expansion initiatives. beHuman is expected to design and launch new products while expanding into additional markets, with specific plans to target broader geographic regions within the US.

The utilization of the recent funding will significantly aid these strategic objectives.